
Tara L. Martinez
Examiner (ID: 16552, Phone: (571)270-1470 , Office: P/1675 )
| Most Active Art Unit | 1654 |
| Art Unit(s) | 1654, 1675 |
| Total Applications | 704 |
| Issued Applications | 357 |
| Pending Applications | 113 |
| Abandoned Applications | 259 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19343521
[patent_doc_number] => 20240252484
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => Methods and Compositions for Treating Vasomotor Symptoms
[patent_app_type] => utility
[patent_app_number] => 18/461812
[patent_app_country] => US
[patent_app_date] => 2023-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17815
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18461812
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/461812 | Methods and Compositions for Treating Vasomotor Symptoms | Sep 5, 2023 | Pending |
Array
(
[id] => 18902703
[patent_doc_number] => 20240018188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => COMPOUNDS FOR SELECTIVE DISRUPTION OF PROTEIN-PROTEIN INTERACTIONS
[patent_app_type] => utility
[patent_app_number] => 18/455139
[patent_app_country] => US
[patent_app_date] => 2023-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22650
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18455139
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/455139 | COMPOUNDS FOR SELECTIVE DISRUPTION OF PROTEIN-PROTEIN INTERACTIONS | Aug 23, 2023 | Pending |
Array
(
[id] => 18902703
[patent_doc_number] => 20240018188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-18
[patent_title] => COMPOUNDS FOR SELECTIVE DISRUPTION OF PROTEIN-PROTEIN INTERACTIONS
[patent_app_type] => utility
[patent_app_number] => 18/455139
[patent_app_country] => US
[patent_app_date] => 2023-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22650
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18455139
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/455139 | COMPOUNDS FOR SELECTIVE DISRUPTION OF PROTEIN-PROTEIN INTERACTIONS | Aug 23, 2023 | Pending |
Array
(
[id] => 19316831
[patent_doc_number] => 20240238371
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => MATERIALS AND METHODS FOR EXTRACELLULAR VESICLE-ASSOCIATED DISEASES
[patent_app_type] => utility
[patent_app_number] => 18/363416
[patent_app_country] => US
[patent_app_date] => 2023-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25890
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18363416
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/363416 | MATERIALS AND METHODS FOR EXTRACELLULAR VESICLE-ASSOCIATED DISEASES | Jul 31, 2023 | Abandoned |
Array
(
[id] => 19808335
[patent_doc_number] => 12239694
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-04
[patent_title] => Methods and compositions for improved cognition
[patent_app_type] => utility
[patent_app_number] => 18/215276
[patent_app_country] => US
[patent_app_date] => 2023-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 17
[patent_no_of_words] => 12752
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18215276
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/215276 | Methods and compositions for improved cognition | Jun 27, 2023 | Issued |
Array
(
[id] => 18552187
[patent_doc_number] => 20230250196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => CELL PENETRATING PROTEIN-ANTIBODY CONJUGATES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/298933
[patent_app_country] => US
[patent_app_date] => 2023-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26099
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18298933
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/298933 | CELL PENETRATING PROTEIN-ANTIBODY CONJUGATES AND METHODS OF USE | Apr 10, 2023 | Abandoned |
Array
(
[id] => 18737990
[patent_doc_number] => 20230346893
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => Methods and Compositions for Preventing or Minimizing Epithelial-Mesenchymal Transition
[patent_app_type] => utility
[patent_app_number] => 18/132517
[patent_app_country] => US
[patent_app_date] => 2023-04-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19024
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18132517
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/132517 | Methods and Compositions for Preventing or Minimizing Epithelial-Mesenchymal Transition | Apr 9, 2023 | Abandoned |
Array
(
[id] => 18707540
[patent_doc_number] => 20230330116
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => MATERIALS AND METHODS FOR SUPPRESSING AND/OR TREATING BONE RELATED DISEASES AND SYMPTOMS
[patent_app_type] => utility
[patent_app_number] => 18/192696
[patent_app_country] => US
[patent_app_date] => 2023-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7429
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18192696
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/192696 | MATERIALS AND METHODS FOR SUPPRESSING AND/OR TREATING BONE RELATED DISEASES AND SYMPTOMS | Mar 29, 2023 | Abandoned |
Array
(
[id] => 18535940
[patent_doc_number] => 20230241026
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => NOVEL DRUG-CONTROLLED SYSTEMS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/173277
[patent_app_country] => US
[patent_app_date] => 2023-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 41323
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18173277
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/173277 | NOVEL DRUG-CONTROLLED SYSTEMS AND USES THEREOF | Feb 22, 2023 | Pending |
Array
(
[id] => 18536069
[patent_doc_number] => 20230241156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => METHODS OF TREATING DISEASE WITH TERLIPRESSIN
[patent_app_type] => utility
[patent_app_number] => 18/105293
[patent_app_country] => US
[patent_app_date] => 2023-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3987
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18105293
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/105293 | METHODS OF TREATING DISEASE WITH TERLIPRESSIN | Feb 2, 2023 | Pending |
Array
(
[id] => 18536069
[patent_doc_number] => 20230241156
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => METHODS OF TREATING DISEASE WITH TERLIPRESSIN
[patent_app_type] => utility
[patent_app_number] => 18/105293
[patent_app_country] => US
[patent_app_date] => 2023-02-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3987
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18105293
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/105293 | METHODS OF TREATING DISEASE WITH TERLIPRESSIN | Feb 2, 2023 | Pending |
Array
(
[id] => 18842685
[patent_doc_number] => 20230405089
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => Heparin-Associated Polypeptides and Uses Thereof
[patent_app_type] => utility
[patent_app_number] => 18/163155
[patent_app_country] => US
[patent_app_date] => 2023-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70683
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18163155
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/163155 | Heparin-Associated Polypeptides and Uses Thereof | Jan 31, 2023 | Abandoned |
Array
(
[id] => 18522236
[patent_doc_number] => 20230232884
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => NUTRITIONAL FORMULA
[patent_app_type] => utility
[patent_app_number] => 18/159363
[patent_app_country] => US
[patent_app_date] => 2023-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67279
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18159363
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/159363 | Nutritional formula | Jan 24, 2023 | Issued |
Array
(
[id] => 18308047
[patent_doc_number] => 20230111947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => METHODS OF PROPHYLAXIS OF CORONAVIRUS INFECTION AND TREATMENT OF CORONAVIRUSES
[patent_app_type] => utility
[patent_app_number] => 18/063229
[patent_app_country] => US
[patent_app_date] => 2022-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44479
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18063229
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/063229 | Methods of prophylaxis of coronavirus infection and treatment of coronaviruses | Dec 7, 2022 | Issued |
Array
(
[id] => 18412116
[patent_doc_number] => 11666643
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-06-06
[patent_title] => Micronutrient combination to reduce blood pressure
[patent_app_type] => utility
[patent_app_number] => 18/070224
[patent_app_country] => US
[patent_app_date] => 2022-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5586
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18070224
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/070224 | Micronutrient combination to reduce blood pressure | Nov 27, 2022 | Issued |
Array
(
[id] => 18509314
[patent_doc_number] => 20230225385
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => Micronutrient combination to reduce blood pressure
[patent_app_type] => utility
[patent_app_number] => 17/994896
[patent_app_country] => US
[patent_app_date] => 2022-11-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6814
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17994896
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/994896 | Micronutrient combination to reduce blood pressure | Nov 27, 2022 | Issued |
Array
(
[id] => 18434399
[patent_doc_number] => 20230181693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => METHODS OF TREATING INFLAMMATORY SKIN DISORDERS
[patent_app_type] => utility
[patent_app_number] => 17/969971
[patent_app_country] => US
[patent_app_date] => 2022-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11971
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17969971
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/969971 | METHODS OF TREATING INFLAMMATORY SKIN DISORDERS | Oct 19, 2022 | Abandoned |
Array
(
[id] => 18198171
[patent_doc_number] => 20230051690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => COMPOSITIONS AND METHODS FOR INHIBITING TUMOR-INDUCED IMMUNE SUPPRESSION
[patent_app_type] => utility
[patent_app_number] => 17/933276
[patent_app_country] => US
[patent_app_date] => 2022-09-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11758
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17933276
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/933276 | COMPOSITIONS AND METHODS FOR INHIBITING TUMOR-INDUCED IMMUNE SUPPRESSION | Sep 18, 2022 | Abandoned |
Array
(
[id] => 18311526
[patent_doc_number] => 20230115426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => PEPTIDES AND PHARMACEUTICAL, NUTRACEUTICAL OR VETERINARY COMPOSITIONS FOR HAIR LOSS PREVENTION AND/OR TREATMENT
[patent_app_type] => utility
[patent_app_number] => 17/944998
[patent_app_country] => US
[patent_app_date] => 2022-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14466
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17944998
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/944998 | PEPTIDES AND PHARMACEUTICAL, NUTRACEUTICAL OR VETERINARY COMPOSITIONS FOR HAIR LOSS PREVENTION AND/OR TREATMENT | Sep 13, 2022 | Pending |
Array
(
[id] => 18537520
[patent_doc_number] => 20230242617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => FIBRONECTIN BASED SCAFFOLD PROTEINS
[patent_app_type] => utility
[patent_app_number] => 17/889123
[patent_app_country] => US
[patent_app_date] => 2022-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36471
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17889123
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/889123 | FIBRONECTIN BASED SCAFFOLD PROTEINS | Aug 15, 2022 | Abandoned |